Harvard Bioscience (HBIO) Accumulated Expenses (2010 - 2026)
Harvard Bioscience (HBIO) reported Accumulated Expenses of $2.2 million for Q1 2026, up 573.37% year-over-year from $323000.0 in Q1 2025, and up 19.83% on a QoQ basis from $1.8 million in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Accumulated Expenses data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Accumulated Expenses rose 573.37% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 573.37% YoY) and the FY2025 annual result came in at $1.8 million, up 5.89% from the prior year.
- Accumulated Expenses climbed to $2.2 million in Q1 2026 per HBIO's latest filing, from $1.8 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $3.9 million in Q4 2023 and bottomed at $242000.0 in Q1 2022.
- The 5-year median for Accumulated Expenses is $1.8 million (2025), against an average of $1.8 million.
- The widest annual swing landed in 2022, when Accumulated Expenses slumped 91.07%; it then surged 1366.04% in 2023.
- Tracing HBIO's Accumulated Expenses over 5 years: stood at $268000.0 in 2022, then surged by 1366.04% to $3.9 million in 2023, then tumbled by 56.38% to $1.7 million in 2024, then increased by 5.89% to $1.8 million in 2025, then gained by 19.83% to $2.2 million in 2026.
- Per Business Quant, the three latest HBIO Accumulated Expenses figures stand at $2.2 million (Q1 2026), $1.8 million (Q4 2025), and $304000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 304,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | 323,000.00 |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 371,000.00 |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 3.93 Mn |
| Sep 30, 2023 | 308,000.00 |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 268,000.00 |
| Sep 30, 2022 | 3.09 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 242,000.00 |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 3.99 Mn |
| Jun 30, 2021 | 237,000.00 |
| Mar 31, 2021 | 2.71 Mn |
| Dec 31, 2020 | 185,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Jun 30, 2020 | 193,000.00 |
| Dec 31, 2019 | 425,000.00 |
| Sep 30, 2019 | 7.47 Mn |
| Jun 30, 2019 | 4.26 Mn |
| Mar 31, 2019 | 5.38 Mn |
| Dec 31, 2018 | 7.35 Mn |
| Sep 30, 2018 | 6.30 Mn |
| Jun 30, 2018 | 7.77 Mn |
| Mar 31, 2018 | 7.69 Mn |
| Dec 31, 2017 | 1.54 Mn |
| Sep 30, 2017 | 4.48 Mn |
| Jun 30, 2017 | 3.73 Mn |
| Mar 31, 2017 | 4.32 Mn |
| Dec 31, 2016 | 4.55 Mn |
| Sep 30, 2016 | 4.50 Mn |
| Jun 30, 2016 | 3.95 Mn |
| Mar 31, 2016 | 5.63 Mn |
| Dec 31, 2015 | 4.02 Mn |
| Sep 30, 2015 | 3.84 Mn |
| Jun 30, 2015 | 4.44 Mn |
| Mar 31, 2015 | 4.27 Mn |
| Dec 31, 2014 | 4.45 Mn |
| Sep 30, 2014 | 4.13 Mn |
| Jun 30, 2014 | 4.62 Mn |
| Mar 31, 2014 | 4.69 Mn |
| Dec 31, 2013 | 5.08 Mn |
| Sep 30, 2013 | 4.37 Mn |
| Jun 30, 2013 | 3.83 Mn |
| Mar 31, 2013 | 4.06 Mn |
| Dec 31, 2012 | 3.51 Mn |
| Sep 30, 2012 | 3.77 Mn |
| Jun 30, 2012 | 3.09 Mn |
| Mar 31, 2012 | 3.69 Mn |
| Dec 31, 2011 | 3.32 Mn |
| Sep 30, 2011 | 3.80 Mn |
| Jun 30, 2011 | 3.65 Mn |
| Dec 31, 2010 | 4.69 Mn |